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Abstract
Background: The ceramide generation is an early event in the apoptotic response to numerous
stimuli including the oxidative stress and ceramide analogs mimic the stress effect and induce
apoptosis. Flavonoids of German chamomile are reported to exhibit the hepatoprotective effect.
Flavonoids affect sphingolipid metabolism and reduce the elevated ceramide level in the aged liver.
In the present paper, the ceramide content and production in the CCl4- and ethanol-treated liver
and hepatocytes as well as the correction of sphingolipid metabolism in the damaged liver using the
mixture of German chamomile flavonoids (chamiloflan) or apigenin-7-glucoside (AP7Glu) have
been investigated.
Results: The experiments were performed in either the rat liver or hepatocytes of normal, CCl4-
and ethanol-treated or flavonoid- and toxin plus flavonoid-treated animals. [14C]palmitic acid and
[methyl-14C-phosphorylcholine]sphingomyelin were used to investigate the sphingolipid turnover.
Addition of the CCl4 or ethanol to isolated hepatocyte suspensions caused loss of cell viability and
increased the lactate dehydrogenase release from the cells into supernatant and ceramide level in
the cells. CCl4  administration to the rats enlarged ceramide mass as well as neutral
sphingomyelinase (SMase) activity and reduced ceramide degradation by the neutral ceramidase.
Pretreatment of isolated hepatocytes with flavonoids abrogated the CCl4 effects on the cell
membrane integrity and normalized the ceramide content. Flavonoid administration to the rats
normalized the elevated ceramide content in the damaged liver via neutral SMase inhibition and
ceramidase activation.
Conclusion: The data obtained have demonstrated that flavonoids affect sphingolipid metabolism
in the CCl4- and ethanol-damaged liver and liver cells. Flavonoids normalized activities of key
enzymes of sphingolipid turnover (neutral SMase and ceramidase) and ceramide contents in the
damaged liver and liver cells, and stabilized the hepatocyte membranes.
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Background
Sphingolipids are a structurally diverse group of com-
pounds composed of a long-chain sphingoid base back-
bone and amino group, which is often substituted with a
long-chain fatty acid. They are found primarily in cell
membranes and are known to play roles in cell-cell and
cell-matrix interactions, and as second messengers [1-4].
In the last years, the regulatory role of ceramide generated
by the sphingomyelin (SM) cycle has received increasing
attention. Sphingomyelinase (SMase) and SM synthase
are the key enzymes of the SM cycle. SMase removes phos-
phocholine from SM to produce ceramide. Once gener-
ated, ceramide could be converted to SM by the SM
synthase activation. In intact cells, the rapid ceramide gen-
eration is an early event in the apoptotic response to
numerous stimuli including the oxidative stress and the
ceramide analogs mimic the stress effect and induce apop-
tosis [2]. It has been recently demonstrated that acid
SMase plays a significant role in hepatocellular apoptosis
and liver damages induced by TNF-α [5]. However, hepa-
toblastoma cell Hep G2 treatment by ethanol was accom-
panied by the neutral SMase activation, ceramide
accumulation and the significant increase of caspase-3
activity and apoptotic cell death [6]. Although the cera-
mides are well known to cause cell death by inducing
apoptosis, they can also cause cell death by necrosis. It has
been determined that incubation of the suspension of
freshly isolated rat hepatocytes in the presence of exoge-
nous short-chain ceramides (C2, C6, C8) induced hepato-
cellular death by necrosis and not apoptosis as confirmed
by the morphology and the absence of internucleosomal
DNA cleavage [7]. The ceramide induced hepatocyte
necrosis was associated with adenosine triphosphate
depletion and mitochondrial depolarization suggesting
that the ceramides caused mitochondrial dysfunction.
A strong correlation exists between the changes in the
SMase activity and in the level of oxidation products
caused by either reduced or oxidized glutathione in the
liver cells [8] and cells of other types [9,10]. Generation of
ceramide has been attributed to serum starvation, Fas-
induced apoptosis [1-4], and cellular senescence studies
[11]. The fact that glutathione depletions frequently
observed in most of these situations suggests that the lev-
els of cellular glutathione regulates the ceramide genera-
tion. It has been determined that at physiologically
relevant concentrations glutathione inhibits the neutral
magnesium-dependent SMase and that the depletion of
cellular glutathione results in the hydrolysis of SM and
generation of ceramide [10]. Studies with analogs and
fragments of glutathione demonstrated that the structural
requirements for inhibition reside in the γ-glutamyl-
cysteine moiety of glutathione. This structural specificity
in inhibiting neutral SMase suggests that glutathione may
function as a specific allosteric regulator of enzyme.
It has been determined that the flavonoids of German
chamomile (chamiloflan) normalized sphingolipid
metabolism in the liver of old rats [11] with an extremely
low, as compared to young animals, level of hepatocellu-
lar glutathione [12]. Both the long- and the short-term
effects of chamiloflan on sphingolipid turnover have been
determined. The flavonoids reducing the SMase activity
decrease the elevated ceramide mass in the old liver down
to the level of adult rats. It has been supposed that, the fla-
vonoids of chamiloflan could reduce the neutral SMase
activity via the elevation of glutathione in the liver.
Such flavonoids, as apigenin-7-glucoside (AP7Glu), lute-
olin-7-glucoside (LU7Glu) and quercitin prevented the
glutathione depletion and lipid peroxidation induced by
an acute intoxication with carbon tetrachloride (CCl4),
ethanol, acetominophen and bromobenzene in the liver
and in the rats with biliary obstruction [13-16]. The best-
described property of almost every group of flavonoids is
their capacity to act as antioxidants [17]. The flavones and
flavonols (apigenin, luteolin, quercetin, rutin and others)
seem to be the most powerful flavonoids for protecting a
body against reactive oxygen species. These compounds
have the potential to scavenge and quench various radi-
cals (oxygen-centered, carbon-centered, alkoxyl, peroxyl,
or phenoxyl radicals) and reactive oxygen species. The fla-
vonoids may have an additive effect to the endogenous
scavenging compounds and also increase the function of
the endogenous antioxidants. The flavonoids interrupt
the lipid peroxidation chain reaction and thereby prevent
glutathione depletion that plays a critical role in cellular
defense against oxidative stress.
The present paper considers the influence of plant
polyphenols on the CCl4- or ethanol-treated liver cell
injury and sphingolipid turnover. Significant increase in
the levels of ceramide, ceramide/SM ratio and neutral
SMase activity has been observed in the cells of CCl4- and
ethanol-treated liver. The flavonoids restored the cera-
mide level and decreased the elevated ceramide/SM ratio
in the damaged liver of CCl4-treated animals or isolated
hepatocytes. The intracellular accumulation of ceramides
in the toxin-treated cells and liver could be prevented by
using the flavonoids of chamiloflan via a mechanism
involving an inhibition of the neutral SMase and the
ceramidase activation.
Results and Discussion
Addition of the CCl4 to isolated hepatocyte suspensions
caused loss of cell viability and an increased LDH release
from the cells into supernatant in a concentration
dependent manner (Figure 1A). Trypan blue staining and
the LDH measurements in the culture medium indicated
that there was no disruption of the normal toxin-
untreated hepatocyte membranes with any of the chami-Lipids in Health and Disease 2008, 7:1 http://www.lipidworld.com/content/7/1/1
Page 3 of 11
(page number not for citation purposes)
loflan flavonoids tested (Figure 1B, C). Chamiloflan or
AP7Glu pretreatment of hepatocytes prevented the CCl4-
induced cell damage. As shown in Figure 2, chamiloflan
and AP7Glu treatments resulted in initial drop of trypan
blue inclusion into the cells and the LDH release from the
hepatocytes into culture medium of the CCl4-treated cells.
It is known, that the synthesis and the degradation of
sphingolipids are regulated by oxidative stress [18]. The
oxidative stress is often associated with the endogenous
ceramide accumulation in the injured cells. The glutath-
ione has been found to be a powerful negative regulator
of the neutral SMase activity in the different cells [9,10].
The elevated content of the ceramide and ceramide/SM
ratio has been found in the CCl4- (Figure 3A) or ethanol-
treated (Figure 4) hepatocytes and in the liver of CCl4-
treated rats (Table 3). It is well documented that cell death
induced by ethanol is associated with stimulation of neu-
tral and acidic SMases and ceramide generation, as well as
with the activation of the stress-related kinases, c-Jun N-
terminal kinase, p38 mitogen-activated protein kinase
and extracellular signal-regulated kinase (ERK) pathways
[6,19,20]. It has been determined, that pharmacological
inhibitors of these kinases largely prevent the apoptosis
induced by the ethanol and C2-ceramide [19]. These
results strongly suggest that ethanol is able to stimulate
the SMase-ceramide pathway, leading to the activation of
signaling pathways implicated in the cell death.
It has been demonstrated that CCl4 as well as ethanol lead
to the pronounced accumulation of ceramide in the liver
cells and stimulate the sphingolipid turnover in the liver.
Using the [methyl-14C-phosphorylcholine]SM, it has
been determined that under the neutral pH conditions the
[14C-methyl]SM content drop, while [14C-methyl]phos-
phorylcholine release from the [14C-methyl]SM
increased in the liver homogenates of CCl4-treated rats, as
compared to the control animals (Figure 5A). The [14C-
methyl]SM hydrolyses at neutral pH was accompanied by
ceramide production in the liver homogenates of the
toxin-treated animals as compared with the control rats
(Figure 5B). The administration of the CCl4 to the rats did
not change the ceramide production (Figure 5B) and
[14C-methyl]SM degradation in the liver homogenates
under the acidic pH (data not shown). The results
obtained strongly demonstrated that the acidic SMase was
not implicated in ceramide accumulation in the CCl4-
treated liver.
Once generated, ceramide can accumulate in the cell or
may be converted into a variety of metabolites. The dea-
cylation of ceramide by either a neutral or acid ceramidase
yields sphingosine, which may then be phosphorylated by
sphingosine kinases to sphingosine 1-phosphate. Cera-
mide may also be converted into SM by a transfer of phos-
phorylcholine from phosphatidylcholine (PC) to
ceramide via SM syntase. [21,22]. It was determined that
the modulation of SM synthase and ceramidase activities
were accompanied by the changes of ceramide levels in
the cells [23,24]. To study the impact of SM synthase and
ceramidase in ceramide accumulation in the toxin-treated
liver the [14C]palmitate-prelabeled ceramide turnover was
analyzed. The administration of the CCl4 to the rats led to
the reduction of the neutral ceramidase activity, the
[14C]sphingosine production and the elevation of the
[14C]palmitate-prelabeled ceramide level in the liver
homogenates (Figure 6). However, CCl4 had no effect on
the [14C]ceramide conversion to SM. The obtained results
demonstrated that the decrease of the ceramide turnover
via ceramidase could led to the lipid accumulation in the
toxin-treated liver.
Recent studies have indicated that ceramide generated in
the liver is secreted into the bloodstream in the form of
very-low-density lipoproteins (VLDL) and low-density
lipoproteins (LDL) [25,26]. Importantly, the changes in
the hepatic serine-palmitoyl transferase activity (the rate-
limiting step in the de novo ceramide synthesis) affect the
rate of the ceramide secretion. The activation of the
enzyme by the addition of palmitic acid leads to an eleva-
tion in VLDL and LDL ceramide. And vice versa, the inhi-
bition of the de novo ceramide synthesis by Fumonisin B1
prevents the incorporation of ceramide in VLDL and LDL.
It has been determined, that CCl4 decreases the lipopro-
tein synthesis in the liver cells and its transport into the
bloodstream [27]. The release of the PC from the CCl4-
treated hepatocytes was less in the magnitude then that
from the control cells (Figure 7). However, CCl4 had no
effect on the ceramide and SM release into the culture
media as compared to the control cells. This result elimi-
nates the role of the ceramide and SM transport from the
cells in the CCl4-induced sphingolipid accumulation in
the isolated hepatocytes.
The flavonoids are reported to exhibit a wide variety of
biological effects, including antioxidant and free radical
scavenging activities, as well as hepatoprotective and anti-
inflammatory effects [17]. Because of their antioxidant
properties, the flavonoids were able to reduce the damage
of hepatocytes and liver induced by chemicals. The intra-
gastric administration of the mixture of chamomile flavo-
noid isomers (such as apigenin, luteolin, AP7Glu,
LU7Glu, isorhamnetin and quercetin (chamiloflan)) to
the adult rats nullified the CCl4-induced increase of serum
alanine aminotransferase, aspartate aminotransferase,
and gamma-glutamyl transpeptidase activities in blood
serum and prevented the hepatocellular fatty degenera-
tion [28]. The intracellular accumulation of ceramides
during aging can be prevented by using the flavonoids ofLipids in Health and Disease 2008, 7:1 http://www.lipidworld.com/content/7/1/1
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Effects of the CCl4 and flavonoids on the hepatocyte death Figure 1
Effects of the CCl4 and flavonoids on the hepatocyte death. The cells (106/ml) were incubated at 37°C in Eagle medium 
containing 10–100 mM CCl4 for 2 h. Control cells were incubated in the presence of 30 mM ethanol for 2 h. Hepatocytes were 
incubated in the presence of the 250–750 μg/ml chamiloflan, or 10–60 μM AP7Glu for 4 h. The time of the control cell suspen-
sion incubation (in the presence of 30 mM ethanol) was 4 h. To determine the cells viability, the trypan blue exclusion into 
hepatocytes and LDH release into supernatant have been studied using commercially available kits. Results are mean ± S.E. of 
six experiments performed in duplicate. * P < 0.05, CCl4 -treated vs. control.Lipids in Health and Disease 2008, 7:1 http://www.lipidworld.com/content/7/1/1
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chamiloflan via a mechanism that involves an inhibition
of the acid and neutral SMases [11].
The pre-treatment of hepatocytes with flavonoids of
chamiloflan or AP7Glu nullified the CCl4- (Figure 3A) or
ethanol-induced (Figure 4) increase of ceramide and cera-
mide/SM ratio. Chamiloflan increased the SM mass in the
toxin treated cells (Figure 3A). However, AP7Glu did not
change the phospholipid content in the CCl4-treated
hepatocytes. The administration of the flavonoids to the
CCl4-treated rats reduced enlarged ceramide mass and
ceramide/SM ratio in the liver, as compared to the control
animals (Table 3). While the flavonoids that were used
had no effect on the untreated normal isolated hepato-
cytes (Figure 3B) and rat liver (Table 3).
The administration of the flavonoids to the CCl4-treated
rats reduced the neutral SMase activity measured by the
release of the [14C]phosphorylcholine from the [14C-
methyl]SM (Figure 5A) and ceramide production in the
liver homogenates (Figure 5B). However, the flavonoids
did not change the [14C-methyl]SM degradation (data not
shown) and the ceramide production under acid pH in
the liver of the CCl4-treated rats (Figure 5B). The results
that were obtained demonstrated that the neutral SMase
could be involved in the flavonoid-associated normaliza-
tion of ceramide production in the toxin-damaged liver
cells. Besides, other pathways of the ceramide turnover
could be influenced by the flavonoids of chamomile. The
administration of the flavonoid to the CCl4-treated rats
decreased the level of the [14C]palmitate-pre-labeled cera-
mide in the liver homogenates and increased its degrada-
tion by the neutral ceramidase to the [14C]sphingosine
(Figure 6). However, chamiloflan did not stimulate the
[14C]palmitate-pre-labeled ceramide conversion to the SM
(Figure 6) and ceramide transport from the CCl4-treated
hepatocytes to the culture media (Figure 7). At the same
time, the flavonoids increased the PC release from the
toxin-damaged hepatocytes into culture media (Figure 7)
and enhanced the lipoprotein synthesis and transport
from the liver cells [17].
The mechanism by which the flavonoids could affect the
sphingolipid turnover has not been explored. It is known
that the generation of ceramide can be regulated by
numerous factors. From the present study, two factors are
worthy of discussion. First, it is known, that AP7Glu,
LU7Glu and quercitin prevented the glutathione deple-
tion and lipid peroxidation induced by an acute intoxica-
tion with the CCl4 or ethanol in the liver [13,14]. The
flavonoids of chamomile (chamiloflan) normalized the
ceramide levels soon after flavonoids addition to the
toxin-treated hepatocytes or injection to the rats. The glu-
tathione has been found to be a powerful negative regula-
tor of neutral SMase activity in the different cells [9,10].
Thus, the flavonoids of chamiloflan could reduce the neu-
tral SMase activity via the elevation of glutathione in the
liver of the CCl4- or ethanol-treated rats or the isolated
liver cells. Second, it is well known that the CCl4- induced
production of the reactive oxygen species coincides with
the phospholipase A2 (PLA2) activation and arachidonic
acid (AA) release in the damaged liver cells [29]. AA is a
known activator of SMase [30] and inhibitor of the ceram-
idase activities in the different cells [31]. It has been deter-
mined that the flavonoids, especially the apeginine and
gurcetine are the inhibitors of PLA2 activity in the toxin-
damaged cells [32-34]. To summarize, the flavonoid-
dependent PLA2 inhibition may be responsible for the
decreased neutral SMase and the increased ceramidase
activities in the CCl4-treated liver cells. Further investiga-
tions are needed to elucidate these conclusions.
Conclusion
Our study suggests that the CCl4 activates the sphingolipid
turnover in the hepatocytes and liver and these effects
mimic the ethanol action on the liver cells. The flavonoids
of chamomile affect the SM and ceramide metabolism in
the toxin-damaged liver and cultured hepatocytes. Both
the ex vivo and the in vivo effects of the plant flavonoids
have been determined. The addition of flavonoid to the
Effects of the flavonoids on the hepatocyte death induced by  the CCl4 Figure 2
Effects of the flavonoids on the hepatocyte death 
induced by the CCl4. The cells (106/ml) were pre-incu-
bated at 37°C in Eagle medium for 2 h followed by the 40 
mM CCl4 addition and suspension was incubated for 2 h. In 
some cases chamiloflan (500 μg/ml) or AP7Glu (30 μM) were 
added to the culture medium 2 h prior the CCl4addition and 
cells incubated for 4 h. Control cells were incubated in the 
presence of 30 mM ethanol for 4 h. To determine the cells 
viability, the trypan blue exclusion into hepatocytes and LDH 
release into supernatant have been studied using commer-
cially available kits. Results are mean ± S.E. of six experi-
ments performed in duplicate. * P < 0.05, CCl4-treated vs. 
control; ** P < 0.05, CCl4+flavonoid-treated vs. CCl4-
treated.Lipids in Health and Disease 2008, 7:1 http://www.lipidworld.com/content/7/1/1
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Effects of the flavonoids on ceramide and sphingomyeline contents in the normal and CCl4-treated hepatocytes Figure 3
Effects of the flavonoids on ceramide and sphingomyeline contents in the normal and CCl4-treated hepato-
cytes. The cells (106/ml) were pre-incubated at 37°C in Eagle medium for 2 h followed by the 40 mM CCl4 addition and sus-
pension was incubated for 2 h. In some cases the chamiloflan (500 μg/ml) or AP7Glu (30 μM) were added to the culture 
medium 2 h prior the CCl4 addition and the cells incubated for 4 h. Control cells were incubated in the presence of 30 mM 
ethanol for 4 h. Lipid contents in the cells were determined as described in the "Materials and Methods". Results are mean ± 
S.E. of six experiments performed in duplicate. * P < 0.05, CCl4-treated vs. control; ** P < 0.05, CCl4+flavonoid-treated vs. 
CCl4-treated.Lipids in Health and Disease 2008, 7:1 http://www.lipidworld.com/content/7/1/1
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culture media or administration to the rats normalized
the elevated ceramide content in the damaged hepato-
cytes or the liver possibly via the neutral SMase inhibition
and the ceramidase activation. The flavonoid-induced
alterations in sphingolipid turnover coincided with the
stabilization of the toxin-treated hepatocyte membranes
and prevented the cell death.
Materials and methods
Materials
[14C]palmitic acid (56.0 mCi/mmol, Amersham, GE
Healthcare UK), [methyl-14C-phosphorylcholine]sphin-
gomyelin (58 mCi/mmol) – Amersham Corp., Silica Gel
Woelm TLC without any binder (ICN Pharmaceuticals
GmbH & Ca.). Lipid standards (ceramide, sphingosine,
PC, SM) were obtained from Sigma (USA). Flavonoids of
German chamomile (chamiloflan), AP7Glu and LU7Glu
were produced by the State Scientific Center of Drugs
(Kharkov, Ukraine). Chamiloflan contains the flavones
(apigenin, luteolin, AP7Glu and LU7Glu) and flavonols
(isorhamnetin and quercetin). Lactate dehydrogenase
(LDH UV SCE) kit was from Felecit Diagnostic, Dnepro-
petrovsk, Ukraine. Other chemicals used were of chemi-
cally pure grade.
Animals
The 90-day-old male Wistar rats were used in the experi-
ments. They had a free access to a standard diet and water
ad libitum and were kept at 24°C on a cycle of 12 h light/
12 h darkness. The animals were divided into several
groups (Table 1). The rats were fed by chamiloflan or eth-
anol intragastrically. CCl4 was injected subcutaneously.
The animals were starved overnight prior to the experi-
ment. All rats were anaesthetized with ketamine (75 mg/
kg) and sacrificed by decapitation. The livers were
obtained 24 h after the last feeding of the rats by chamilo-
flan or ethanol or after CCl4 administration
Experiments with Liver Homogenates
The liver was perfused with 0.9% NaCl, then removed and
washed in Krebs-Henseleit buffer, pH 7.4, containing 2
mM CaCl2 and 0.2% BSA. Liver homogenates prepared in
50 mM Tris-HCl, pH 7.4, 1 mM EDTA, 10 mM magne-
sium chloride, 0.65% Triton X-100 or 50 mM sodium ace-
tate, pH 5.0 were used to determine the SMases activities
as described below. For lipid separation the liver homoge-
nates were prepared in the Krebs-Henseleit buffer, pH 7.4.
Effects of the flavonoids on ceramide and sphingomyeline  contents in the normal and ethanol-treated hepatocytes Figure 4
Effects of the flavonoids on ceramide and sphingomy-
eline contents in the normal and ethanol-treated 
hepatocytes. The cells (106/ml) were incubated at 37°C in 
Eagle medium containing 70 mM ethanol for 4 h. Control 
cells were incubated without any additions for 4 h. In some 
cases, the chamiloflan (500 μg/ml) or AP7Glu (30 μM) were 
added to the culture medium together with the ethanol addi-
tion and cells incubated for 4 h. The ethanol concentration in 
the flavonoid-treated cell suspension was 70 mM. Lipid con-
tents in the cells were determined as described in the "Mate-
rials and Methods". Results are mean ± S.E. of six 
experiments performed in duplicate. * P < 0.05, ethanol-
treated vs. control; ** P < 0.05, ethanol+flavonoid-treated vs. 
ethanol-treated.
Table 3: Effects of the chamiloflan on the ceramide content in the liver of the normal and CCl4-treated rats.
Animals Ceramide Ceramide/SM
Un-treated 6.74 ± 0.54 0.131 ± 0.010
Control (1) 6.95 ± 0.45 0.121 ± 0.015
Chamiloflan-treated 6.83 ± 0.23 0.112 ± 0.005
Control (2) 5.67 ± 0.46 0.117 ± 0.010
CCl4-treated 7.34 ± 0.47 * 0.162 ± 0.013 *
Chamiloflan + CCl4-treated 5.93 ± 0.51 0.135 ± 0.017
The rats were fed by the chamiloflan (160 mg/kg body weight) or ethanol (1 %, 5 ml/kg body weight) (control 1 group) intragastrically daily for 6 
days. The CCl4 (50 % in corn oil, 4 ml/kg body weight) was injected subcutaneously daily for 4 days. Some of the CCl4- treated rats were fed by the 
chamiloflan (160 mg/kg body weight) daily for 6 days intragastrically. Control (2) rats were injected subcutaneously by the corn oil (2 ml/kg body 
weight) daily for 4 days and fed by the ethanol (1 %, 5 ml/kg body weight) daily for 6 days. The animals were starved overnight prior the 
experiments. The amount of the ceramides in the liver homogenate was represented as nmol per mg of protein. Results are mean ± SE of 10 
experiments performed in duplicate. * R < 0.05, CCl4-treated rats vs. control.Lipids in Health and Disease 2008, 7:1 http://www.lipidworld.com/content/7/1/1
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The lipids were extracted and analyzed as described
below.
Experiments with hepatocytes
Hepatocytes were isolated from the 90-day-old male Wis-
tar normal rats by the method described in [35]. The prep-
aration of hepatocytes started between 9:00 and 10:00
a.m. The cells (106/ml) were cultured on the 60 mm Petri
dishes coated with rat tail collagen [36] in Eagle medium
containing 10% fetal calf serum, 100 units/liter strepto-
mycin, 100 units/liter penicillin, 13 mg/ml gentamycin in
a humidified atmosphere of 5% CO2 in a tissue culture
incubator at 37°C. The rat hepatocytes were incubated in
the presence of 250–750 μg/ml chamiloflan or 10–60 μM
AP7Glu for 4 h. The control cell cultures contained 30 μM
ethanol. In some cases the hepatocytes were incubated in
the presence of 10–100 mM CCl4 or 70 μM ethanol. The
treatment protocol was demonstrated in Table 2. The cells
were released from the dishes by a mild trypsin treatment.
The hepatocytes were allowed to settle and the pellet was
resuspended in the Krebs-Henseleit buffer, pH 7.4, con-
taining 2 mM CaCl2, 25 mM HEPES, 0.1% BSA. To deter-
mine the cells viability, the trypan blue exclusion into
hepatocytes and LDH release into supernatant have been
studied using commercially available kits. To obtain the
[14C]-labeled ceramide the isolated hepatocytes were
incubated in the Eagle medium containing 10% fetal calf
serum, 100 units/liter streptomycin, 100 units/liter peni-
cillin, 13 mg/ml gentamycin and 2.5 μCi/ml [14C]palmitic
Effects of the flavonoids on the ceramide turnover induced in  the liver by the CCl4 Figure 6
Effects of the flavonoids on the ceramide turnover 
induced in the liver by the CCl4. CCl4 (50% in corn oil, 4 
mg/kg body weight) was injected to rats subcutaneously daily 
for 4 days and fed by ethanol (1 %, 5 ml/kg body weight) daily 
for 6 days Some of the animals were fed by chamiloflan (160 
mg/kg body weight) daily for 4 days together with CCl4 injec-
tions and 2 days after last CCl4treatment. Control rats were 
injected subcutaneously by corn oil (2 ml/kg body weight) 
daily for 4 days and fed by ethanol (1 %, 5 ml/kg body weight) 
daily for 6 days. Liver homogenates were used for the deter-
mination of ceramide turnover. To study the ceramide con-
version to SM and sphingosyne, the [14Cpalmitate-pre-
labeled [14C]ceramide was used. Lipid extraction and separa-
tion were determined as described in the "Materials and 
Methods". Results are mean ± S.E. of six experiments per-
formed in duplicate. * P < 0.05, CCl4-treated vs. control; ** P 
< 0.05, CCl4+flavonoid-treated vs. CCl4-treated.
Effects of the flavonoids on the shingomyelinase activity and  ceramide production induced in the liver by the CCl4 Figure 5
Effects of the flavonoids on the shingomyelinase 
activity and ceramide production induced in the liver 
by the CCl4. CCl4 (50% in corn oil, 4 mg/kg body weight) 
was injected to rats subcutaneously daily for 4 days and fed 
by ethanol (1 %, 5 ml/kg body weight) daily for 6 days Some 
of the animals were fed by chamiloflan (160 mg/kg body 
weight) daily for 4 days together with CCl4 injections and 2 
days after last CCl4 treatment. Control rats were injected 
subcutaneously by corn oil (2 ml/kg body weight) daily for 4 
days and fed by ethanol (1 %, 5 ml/kg body weight) daily for 6 
days. Liver homogenates were used for the determination of 
the neutral SMase activity (pH 7.4) (A) and ceramide genera-
tion under neutral (pH 7.4) and acidic (pH 4.5) conditions (B) 
as described in the "Materials and Methods". The [methyl-
14C-phosphorylcholine]sphingomyelin as a substrate was 
used. Results are mean ± S.E. of six experiments performed 
in duplicate. * P < 0.05, CCl4-treated rats vs. control; ** P < 
0.05, CCl4+flavonoid-treated rats vs. CCl4-treated.Lipids in Health and Disease 2008, 7:1 http://www.lipidworld.com/content/7/1/1
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acid for 24 h. During the incubation, the cells were main-
tained at 37°C and humidified atmosphere of 5% CO2 in
a tissue culture incubator. Before the lipid extraction, the
cells were washed twice with the Krebs-Henseleit buffer,
pH 7.4, containing 2 mM CaCl2, 25 mM HEPES, 0.1%
BSA. The lipids were extracted and [14C]ceramide was iso-
lated as described below.
Determination of sphingolipid metabolism
The activities of neutral and acid SMases were determined
using the liver cells homogenates and [methyl-14C-phos-
phorylcholine]sphingomyelin (58 mCi/mmol) [37]. The
reaction mixture contained liver homogenate in 50 mM
Tris-HCl, pH 7.4, 1 mM EDTA, 10 mM magnesium chlo-
ride, 0.65% Triton X-100 and 2 mM [methyl-14C]sphingo-
myelin in a final volume of 200 μl. The reaction
proceeded up to 1 h at 37°C and was then terminated by
the addition of 1.5 ml of chloroform/methanol (1:2, v/v)
followed by 1 ml of chloroform and 1 ml of H2O. The
mixture was centrifuged for 5 min at 3,000 rpm. After
phase separation, a portion of the upper, aqueous phase
containing [14C]phosphorylcholine was removed and the
radioactivity determined by liquid scintillation counting.
To determine the remained [methyl-14C]sphingomyelin
and unlabeled ceramide formation the lower phase was
analyzed as described below. To study the ceramide con-
version to SM and sphingosyne, the [14Cpalmitate-pre-
labeled [14C]ceramide was used [38]
Extraction and Separation of Lipids
The lipids were extracted according to the Bligh and Dyer
protocol [39]. The chloroform phase was collected and
dried under N2 at 37°C. The lipids were redissolved in
chloroform/methanol (1:2, v/v) and applied on the TLC
plates. The plates for lipid separation were prepared from
Silica Gel Woelm TLC without any binder. The layer thick-
ness was 0.25 mm. For the PC separation the solvent sys-
tem: chloroform/methanol/acetic acid/water (25:15:4:2,
v/v) was used. For the ceramide and SM separation, the
plates with loaded lipid extract were developed with die-
thyl ether. When the solvent front reached the top of the
plate, the plate was removed from the chamber, dried, and
developed again with chloroform/methanol/water
(40:10:1, v/v). In this case, the solvent front was allowed
to reach 2/3 of the plate length. The regions migrating
with the standart ceramide and SM were scraped from the
plate and the ceramide eluted from the silica with 1 ml
chloroform:methanol (1:1, v/v) followed by 1 ml of
methanol. The combined eluates were dried in vacuo, and
the ceramide mass was quantified by long chain bases
released after an acid hydrolysis in 0.5 M HCl in methanol
at 65°C for 15 h [40]. Free long chain bases were analyzed
as described by Lauter & Trams [41]. The contents of phos-
pholipids in chromatographic fractions were determined
by the method of [42]. Samples for isolation of free
[14C[sphingosine (Sph) were prepared as recommended
Table 1: Experimental protocol: experiments with the animals.
Animals Treatments:
Ethanol (1 %) Corn oil CCl4 
(50 %, dissolved in corn oil)
Chamiloflan 
(dissolved in 1 % ethanol)
U n - t r e a t e d --- -
Control (1) 5 ml/kg body weight for 6 days - - -
Chamiloflan-treated - - - 160 mg/kg body weight for 6 days
Control (2) 5 ml/kg body weight for 6 days 2 ml/kg body weight for 4 days - -
CCl4-treated 5 ml/kg body weight for 6 days - 4 ml/kg body weight for 4 days -
Chamiloflan + CCl4-treated - - 4 ml/kg body weight for 4 days 160 mg/kg body weight for 6 days
Effects of the flavonoids on ceramide, sphingomyelin and  phosphatidylcholine release from the hepatocytes pre- treated by the CCl4 Figure 7
Effects of the flavonoids on ceramide, sphingomyelin 
and phosphatidylcholine release from the hepato-
cytes pre-treated by the CCl4. The cells (106/ml) were 
incubated at 37°C in Eagle medium containing 30 μM ethanol 
for 2 h followed by 40 mM CCl4treatment for 2 h. Chamilof-
lan (500 μg/ml) was added to the culture medium 2 h prior 
40 mM CCl4 addition and cells incubated for 4 h. Control 
cells were incubated in the media containing 30 μM ethanol 
for 4 h. Lipid contents in the culture medium were deter-
mined as described in the "Materials and Methods". Results 
are mean ± S.E. of six experiments performed in duplicate. * 
P < 0.05, CCl4-treated vs. control; ** P < 0.05, CCl4+flavo-
noid-treated vs. CCl4-treated.Lipids in Health and Disease 2008, 7:1 http://www.lipidworld.com/content/7/1/1
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in [43] and Sph separation was performed by TLC in the
solvent system: chloroform/methanol/ammonium
hydroxide (40:10:1, v/v). The appropriate standards were
applied on each plate for quantification. The gel spots
containing [14C]lipids were scraped and transferred to
scintillation vials. Radioactivity was measured by a scintil-
lation counter.
Statistical analyses
One-way analysis of variance (ANOVA) procedures was
used to assess significant differences among treatment
groups. For each significant effect of treatment, the Fisher
LSD and Turky HSD tests were used for comparison of
multiple group means. Student's t-test was used for paired
observations and significance was set at p < 0.05 and p <
0.001.
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